Michael L. Moehn - Jun 1, 2023 Form 4 Insider Report for AMEREN CORP (AEE)

Signature
Jonathan T. Shade, Deputy Corp. Secy. of Ameren Corporation, attorney-in-fact for Michael L. Moehn
Stock symbol
AEE
Transactions as of
Jun 1, 2023
Transactions value $
-$249,850
Form type
4
Date filed
6/5/2023, 04:19 PM
Previous filing
Mar 2, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEE Common Stock, $.01 Par Value Sale -$250K -3.08K -1.84% $81.12 164K Jun 1, 2023 Direct F2, F3
holding AEE Common Stock, $.01 Par Value 4.76K Jun 1, 2023 By 401(K) F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the estimated number of share equivalents held by the reporting person in the unitized stock fund included in the Ameren Corporation Savings Investment Plan as of May 31, 2023.
F2 Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.89 to $81.20, inclusive. The reporting person undertakes to provide Ameren Corporation (Ameren), any security holder of Ameren, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 Amount includes 338 accrued dividend equivalents acquired during the first quarter of 2023 pursuant to a dividend reinvestment feature of restricted stock units granted under the issuer's 2022 Omnibus Incentive Compensation Plan and 2014 Omnibus Incentive Compensation Plan.